Equity Profile

CNTA

Centessa Pharmaceuticals plc

Health CareBiotechnology$6.2B

Aug11Tue

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Centessa Pharmaceuticals plc is a biotechnology company focused on developing innovative therapies for serious diseases. Operating in the health care sector, its work is crucial as it aims to address unmet medical needs through advanced drug development.

Key Metrics to Watch

EPS (Earnings Per Share)

EPS is a key indicator of the company's profitability and will help gauge how well Centessa is managing its expenses relative to revenue.

N/A

Revenue Growth

While specific revenue estimates are not available, any growth in revenue would signal successful product development and market acceptance.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

CNTA Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

-51.59%

Avg Stock Reaction

+6.48%

Last Quarter Recap

In Q1-2026, Centessa reported an EPS of -$0.52, missing expectations by a significant margin. The stock reacted with a slight decline of 0.08% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautious ahead of the earnings report, given the company's recent performance and lack of analyst estimates. The market is looking for any signs of improvement in profitability and revenue.

Bull Case

If Centessa can show a narrower loss or even a surprise profit, it could boost investor confidence and lead to a positive stock reaction.

Bear Case

Conversely, another significant earnings miss could raise concerns about the company's financial health and future prospects, potentially leading to a sharp decline in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the updated EPS forecast for Q2-2026?

A clearer EPS forecast will help investors assess the company's path to profitability and gauge management's confidence in their financial strategy.

How has R&D spending impacted the product pipeline?

Understanding the relationship between R&D investments and product development will be crucial for evaluating Centessa's future growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Centessa to narrow its losses significantly this quarter, given its ongoing R&D efforts.

Supporting Evidence

The options market is pricing a 17.42% move, suggesting expectations of volatility that may not align with the company's actual performance.

Historical data shows that the stock has reacted positively to smaller-than-expected losses in the past.

Key Risk

If EPS comes in better than -$0.50, it could shift the narrative around Centessa's financial health.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it could set the tone for future investor sentiment and the company's ability to execute its strategy.

Bull Confirmed If

A narrower loss of less than -$0.50 in EPS would confirm the bull case and indicate improved financial management.

Bear Confirmed If

An EPS loss greater than -$0.60 would confirm the bear case, raising concerns about the company's financial sustainability.

Pre-Earnings Positioning

Options Market

Implied Move

±17.42%

Historical Avg

±8.2%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±17.4% while CNTA has averaged ±8.2% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.2%

30d HV

2.5%

Calls (5K)P/C Ratio: 27.83Puts (3K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Centessa beats expectations, history suggests the stock could see an average one-day move of +0.04%, confirming improved investor sentiment.

In-Line / Cautious

A cautious in-line report may lead to muted stock movement as investors digest management's commentary on future prospects.

Miss

If the company misses expectations again, history suggests an average one-day move of +8.63%, indicating potential selling pressure.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on the product pipeline and expected timelines for upcoming trials.
2Details on R&D spending and its impact on future revenue.
3Management's outlook on market conditions and competitive landscape.
4Insights into partnerships or collaborations that could enhance growth.
5Clarification on any changes in strategic direction or focus areas.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug10

BWBMO

Babcock & Wilcox Enterprises, Inc.

PreviewView

Aug10

ROIVBMO

Company Snapshot

Key Metrics to Watch

EPS (Earnings Per Share)

EPS is a key indicator of the company's profitability and will help gauge how well Centessa is managing its expenses relative to revenue.

N/A

Revenue Growth

While specific revenue estimates are not available, any growth in revenue would signal successful product development and market acceptance.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

CNTA Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

-51.59%

Avg Stock Reaction

+6.48%

Last Quarter Recap

In Q1-2026, Centessa reported an EPS of -$0.52, missing expectations by a significant margin. The stock reacted with a slight decline of 0.08% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Centessa can show a narrower loss or even a surprise profit, it could boost investor confidence and lead to a positive stock reaction.

Bear Case

Conversely, another significant earnings miss could raise concerns about the company's financial health and future prospects, potentially leading to a sharp decline in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the updated EPS forecast for Q2-2026?

A clearer EPS forecast will help investors assess the company's path to profitability and gauge management's confidence in their financial strategy.

How has R&D spending impacted the product pipeline?

Understanding the relationship between R&D investments and product development will be crucial for evaluating Centessa's future growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Centessa to narrow its losses significantly this quarter, given its ongoing R&D efforts.

Supporting Evidence

The options market is pricing a 17.42% move, suggesting expectations of volatility that may not align with the company's actual performance.

Historical data shows that the stock has reacted positively to smaller-than-expected losses in the past.

Key Risk

If EPS comes in better than -$0.50, it could shift the narrative around Centessa's financial health.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it could set the tone for future investor sentiment and the company's ability to execute its strategy.

Bull Confirmed If

A narrower loss of less than -$0.50 in EPS would confirm the bull case and indicate improved financial management.

Bear Confirmed If

An EPS loss greater than -$0.60 would confirm the bear case, raising concerns about the company's financial sustainability.

Pre-Earnings Positioning

Options Market

Implied Move

±17.42%

Historical Avg

±8.2%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±17.4% while CNTA has averaged ±8.2% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.2%

30d HV

2.5%

Calls (5K)P/C Ratio: 27.83Puts (3K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Centessa beats expectations, history suggests the stock could see an average one-day move of +0.04%, confirming improved investor sentiment.

In-Line / Cautious

A cautious in-line report may lead to muted stock movement as investors digest management's commentary on future prospects.

Miss

If the company misses expectations again, history suggests an average one-day move of +8.63%, indicating potential selling pressure.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on the product pipeline and expected timelines for upcoming trials.
2Details on R&D spending and its impact on future revenue.
3Management's outlook on market conditions and competitive landscape.
4Insights into partnerships or collaborations that could enhance growth.
5Clarification on any changes in strategic direction or focus areas.